mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.003 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.003 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.003 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.003 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.004 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.006 |